Opinions of Friday, 28 February 2025
Columnist: Bright Simmons
Sweet and beguiling poisons
Barely a week ago, the BBC aired a documentary with a harrowing message: deadly opioids made in India have flooded Ghana’s market, creating throngs of enslaved addicts.
Chilling footage showed the Chief Executive (CEO) of a Mumbai-based pharma company, Aveo Pharmaceuticals, a man called Vinod Sharma, brazenly confessing to undercover journalists how poisonous a certain concoction he has dreamt up is to the bodies of those unfortunate enough to become addicted. All these facts were delivered deadpan amidst bouts of intense self-praise of his own ingenuity.
Vinod’s concoction, Tafrodol, is a combination of a powerful and addictive painkiller, Tapentadol, and a strong muscle relaxant, Carisoprodol. Each drug is considered risky enough that it has been placed in “controlled” categories or outrightly banned in several countries, as is the case with Carisoprodol in the European Union (EU), for instance. When combined, however, their risks accelerate through the roof.